Equillium, Inc. — Director's Dealing 2020

Jul 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2020-07-13

Reporting Person: Connelly Stephen (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-13	Common Stock	S	250000	$8.1339	Disposed	1043000	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 24, 2020.

F2: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $8.1339. The range of sale prices on the transaction date was $7.50 to $9.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.